Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dunger

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
BMC Pediatrics|August 19, 2007
A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe)Kathryn Beardsall, Sophie Vanhaesebrouck, Amanda L Ogilvy-Stuart, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 3, 2016
Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant developmentAnn Hellström, David Ley, Ingrid Hansen-Pupp, et al.
Lancet (London, England)|August 28, 2015
Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetesHood Thabit, Daniela Elleri, Lalantha Leelarathna, et al.
Diabetes Care|February 25, 2016
Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions: A White Paper From the NICHD Diabetes Working GroupWilliam V Tamborlane, Morey W Haymond, David Dunger, et al.
Diabetologia|January 10, 2020
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetesMarco Colombo, Stuart J McGurnaghan, Luke A K Blackbourn, et al.
Diabetes Care|July 30, 2014
Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)Oana Maftei, Alexia S Pena, Thomas Sullivan, et al.
Frontiers in Pediatrics|November 9, 2020
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: <i>Post-hoc</i> Analysis of Its Effect on Brain InjurySandra Horsch, Alessandro Parodi, Boubou Hallberg, et al.
The Journal of Clinical Endocrinology and Metabolism|October 7, 2016
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice GuidelineRebecca J Brown, David Araujo-Vilar, Pik To Cheung, et al.
Diabetologia|October 6, 2018
Serum kidney injury molecule 1 and β<sub>2</sub>-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetesMarco Colombo, Helen C Looker, Bassam Farran, et al.
Ebiomedicine|May 24, 2023
Gene expression signature predicts rate of type 1 diabetes progressionTomi Suomi, Inna Starskaia, Ubaid Ullah Kalim, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
BMC Pediatrics|August 19, 2007
A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe)Kathryn Beardsall, Sophie Vanhaesebrouck, Amanda L Ogilvy-Stuart, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 3, 2016
Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant developmentAnn Hellström, David Ley, Ingrid Hansen-Pupp, et al.
Lancet (London, England)|August 28, 2015
Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetesHood Thabit, Daniela Elleri, Lalantha Leelarathna, et al.
Diabetes Care|February 25, 2016
Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions: A White Paper From the NICHD Diabetes Working GroupWilliam V Tamborlane, Morey W Haymond, David Dunger, et al.
Diabetologia|January 10, 2020
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetesMarco Colombo, Stuart J McGurnaghan, Luke A K Blackbourn, et al.
Diabetes Care|July 30, 2014
Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)Oana Maftei, Alexia S Pena, Thomas Sullivan, et al.
Frontiers in Pediatrics|November 9, 2020
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: <i>Post-hoc</i> Analysis of Its Effect on Brain InjurySandra Horsch, Alessandro Parodi, Boubou Hallberg, et al.
The Journal of Clinical Endocrinology and Metabolism|October 7, 2016
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice GuidelineRebecca J Brown, David Araujo-Vilar, Pik To Cheung, et al.
Diabetologia|October 6, 2018
Serum kidney injury molecule 1 and β<sub>2</sub>-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetesMarco Colombo, Helen C Looker, Bassam Farran, et al.
Ebiomedicine|May 24, 2023
Gene expression signature predicts rate of type 1 diabetes progressionTomi Suomi, Inna Starskaia, Ubaid Ullah Kalim, et al.
Pageof 7